Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
Objective: Tenofovir is among the first-line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy and safety of Tenofovir in treatment of Iranian patients with CHB. Methods: Forty treatment-native patients with CHB but without concurrent hepatitis C or human immunodef...
Main Authors: | Behrooz Ataei, Mahsa Khodadoostan, Babk Pouria, Peyman Adibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Research in Pharmacy Practice |
Subjects: | |
Online Access: | http://www.jrpp.net/article.asp?issn=2319-9644;year=2016;volume=5;issue=3;spage=166;epage=170;aulast=Ataei |
Similar Items
-
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01) -
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
by: Hee Yeon Seo, et al.
Published: (2017-06-01) -
Evaluation of the Efficacy of Entecavir and Tenofovir in the Treatment of Chronic Hepatitis B: A Retrospective Study
by: Arzu ŞENOL, et al.
Published: (2019-12-01) -
Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
by: Mireia Miquel, et al.
Published: (2013-03-01) -
Efficacy and safety on tenofovire therapy in patients with hepatitis B viral infections resistent to lamivudin
by: Katanić N., et al.
Published: (2015-01-01)